A61K 38/486
Elastase
Official title: {Elastase (3.4.21.36 or 3.4.21.37)}
A61K38/486 (Elastase) appears on 41 US grants and 74 published applications in this corpus.
Search patents in A61K- Granted patents
- 41
- Published applications
- 74
- Assignees
- 28
- Inventors
- 71
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 1 |
| 2002 | 1 | 1 |
| 2003 | 0 | 2 |
| 2004 | 0 | 3 |
| 2005 | 0 | 6 |
| 2006 | 2 | 1 |
| 2007 | 0 | 3 |
| 2008 | 2 | 1 |
| 2009 | 1 | 8 |
| 2010 | 1 | 4 |
| 2011 | 3 | 5 |
| 2012 | 2 | 2 |
| 2013 | 5 | 4 |
| 2014 | 1 | 2 |
| 2015 | 2 | 5 |
| 2016 | 3 | 4 |
| 2017 | 0 | 2 |
| 2018 | 1 | 3 |
| 2019 | 4 | 5 |
| 2020 | 1 | 2 |
| 2021 | 1 | 3 |
| 2022 | 3 | 2 |
| 2023 | 2 | 2 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions related to therapeutic peptides for cancer therapy28 Apr 2026US 12,611,443 B2The University of Chicago
- Peptide therapeutics for treating Alzheimer's disease and related conditions4 Mar 2025US 12,241,099 B2The Board of Regents of the University of Oklahoma
- Use of serine protease inhibitors in the treatment of skin diseases24 Oct 2023US 11,793,864 B2Dermadis SA
- Methods of treating neurological disorders12 Sep 2023US 11,752,200 B2EnClear Therapies, Inc.
- Methods of treating neurological disorders23 Aug 2022US 11,419,921 B2EnClear Therapies, Inc.
- Improved downregulation of histone cytotoxicity by complex of negatively charged polysaccharide and protease3 Sep 2026US 2026/0256895 A1Academisch Ziekenhuis Maastricht
- Methods and compositions related to therapeutic peptides for cancer therapy23 Jul 2026US 2026/0207707 A1The University of Chicago
- Systems and methods for epicardial tissue distension solutions12 Mar 2026US 2026/0069665 A1Edwards Lifesciences Corporation
- Methods of treating neurological disorders23 Feb 2023US 2023/0056486 A1EnClear Therapies, Inc.
- Method for Producing Peptide Ace Inhibitors9 Feb 2023US 2023/0041686 A1St. Marie Intellectual Property Holdings, LLC
Most cited
By later US patents
- Engineered enzymes and uses thereof79US 7,335,504 B2DIREVO Biotechnology AG · 2008
- Reduced-pressure treatment systems and methods employing debridement mechanisms75US 8,486,032 B2KCI Licensing, Inc. · 2013
- Compositions and methods for reducing lung volume36US 7,819,908 B2Aeris Therapeutics, Inc. · 2010
- Methods for treating an artery or vein in a human subject10US 7,063,838 B1Proteon Therapeutics, Inc. · 2006
- Burn treatment9US 4,276,281 A1981